期刊文献+

健脾补肾法对人结直肠癌移植瘤组织TLR4、RAGE、NF-κB及CD34、D2-40的影响

Effects of Spleen-and-Kidney Invigorating Method on TLR4,RAGE,NF-κB,CD34,D2-40 in Human Colorectal Cancer Transplanted Tumor Tissue
下载PDF
导出
摘要 目的探讨健脾补肾法对人结直肠癌移植瘤组织TLR4、RAGE、NF-κB及CD34、D2-40的影响。方法于裸鼠右腿内侧接种人结肠癌细胞,建立人结肠癌裸鼠皮下移植瘤模型,15d后脱颈处死剥离瘤体。对照组用生理盐水灌胃,实验组用健脾补肾中药灌胃,免疫组化法检测2组移植瘤组织中TLR4、RAGE、NF-κB及CD34、D2-40的表达。结果免疫组化显示,与对照组相比,实验组的移植瘤组织中TLR4、RAGE、NF-κB的表达均明显下调(P<0.05),微血管CD34及淋巴管D2-40也明显下调(P<0.005)。结论健脾补肾法能明显下调人结直肠癌移植瘤组织炎症受体TLR4及RAGE、核转录因子NF-κB、肿瘤新生血管标记物CD34及肿瘤新生淋巴管标记物D2-40的表达。 To study the effect of spleen-and-kidney invigorating method on TLR4,RAGE,NF-κB,CD34,D2-40 in human colorectal cancer transplanted tumor tissue.Methods:Human colorectal cancer cells were inoculated on the inside of the right leg of nude mice to establish a subcutaneous tumor transplantation model of human colorectal cancer in nude mice and the mice was sacrificed to remove the tumor from the neck 15 days later.The control group was given intragastric administration with normal salt and the experimental group was intragastrically given with decoction for invigorating spleen and kidney.The expressions of TLR4,RAGE,NF-κB,CD34 and D2-40 in the transplanted tumor tissues were detected by immunohistochemical method.Results:Compared with that of the control group,the expressions of TLR4,RAGE and NF-κB in the experimental group were significantly down-regulated(P<0.05),and the expressions of CD34 in microvessels and D2-40 in lymphatic vessels were also significantly down-regulated(P<0.005).Conclusion:The spleen-and-kidney invigorating method can significantly down-regulate the expression of inflammatory receptor TLR4 and RAGE,nuclear transcription factor NF-κB,tumor neovascularization marker CD34 and tumor neovascularization marker D2-40 in human colorectal cancer graft tissue.
作者 王梦涵 姚欣 袁婉婧 李梅 黄兴瑜 孙怡 曾宏亮 谢彪 WANG Meng-han;YAO Xin;YUAN Wan-jing;LI Mei;HUANG Xing-yu;SUN Yi;ZENG Hong-liang;XIE Biao(Hunan University of Traditional Chinese Medicine,Changsha 410208,China;The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410005,China;Hunan Institute of Traditional Chinese Medicine,Changsha 410031,China)
出处 《云南中医中药杂志》 2023年第3期78-82,共5页 Yunnan Journal of Traditional Chinese Medicine and Materia Medica
基金 湖南省中医药管理局科研项目(湘中医药函〔2020〕51号) 长沙市杰出创新计划(kq1707012) 2021年湖南中医药大学校级科研基金与联合基金项目(2021XJJJ067)。
关键词 健脾补肾法 结直肠癌 TLR4 RAGE NF-ΚB CD34 D2-40 Spleen-And-Kidney Invigorating Method Colorectal Cancer TLR4 RAGE NF-κB CD34 D2-40
  • 相关文献

参考文献7

二级参考文献67

  • 1李莎,刘蕊.2型糖尿病患者发生结直肠癌影响因素的研究进展[J].中国老年学杂志,2014,34(4):1154-1156. 被引量:2
  • 2Zhang X,Shan P, Qureshi S,et al.TLR4 deficiency confers sus- ceptibility to lethal oxidant hmg injury.J Immuno,2005,175(8): 4834-4838.
  • 3Sato Y,Goto Y,Narita N,et al.Cancer cells expressing Toll-like receptors and the tumormicroenvironment.Cancer Microenviron, 2009,2(1):205-214.
  • 4Yang H,Zhou H,Feng P,et al.Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.J Exp Clin Cancer Res,2010,10(29):92.
  • 5Szczepanski M J,Czystowska M,Szajnik M,et al.Triggering of Toll- like receptor 4 expressed on human head and neck squamous cell carci-noma promotes tumordevelopmentand protects the tumor from immune attack.Cancer Res,2009,69(7):3105-3113.
  • 6Zhang J J,Wu H S,Wang L,et ahExpression and significance of TLR4 and HIF-lalpha in pancreatic ductal adenocarcinoma.World J Gastroentero,2010,16(23):2881-2888.
  • 7MantovaniA,Allavena P,Sica A,et al.Cancer-related inflammation. Nature,2008,454(7203):436-444.
  • 8Mantovani A.Molecular pathways linking inflammation and cancer. Curr Mol Med,2010,10(4):369-373.
  • 9Wang E L,Qian Z R,Nakasono M,et al.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.Br J Cancer,2010,102(5):908- 915.
  • 10He W,Liu Q,WangL, et al.TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance.Mol Immuno,2007,44(11): 2850-2859.

共引文献1437

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部